STUDY "A MULTICENTER, LONGITUDINAL, PROSPECTIVE, PHARMACOKINETIC, PHASE 1B STUDY IN WOMEN WITH CHRONIC INFLAMMATORY DISEASES TREATED WITH CIMZIA® (CERTOLIZUMAB PEGOL) DURING PREGNANCY"
Clinical Trial Grant
Administered By
Medicine, Rheumatology and Immunology
Awarded By
UCB Pharma, Inc.
Start Date
February 5, 2020
End Date
January 31, 2024
Administered By
Medicine, Rheumatology and Immunology
Awarded By
UCB Pharma, Inc.
Start Date
February 5, 2020
End Date
January 31, 2024